Growth Metrics

Bruker (BRKR) Change in Accured Expenses (2016 - 2025)

Bruker (BRKR) has disclosed Change in Accured Expenses for 15 consecutive years, with $66.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 696.4% year-over-year to $66.2 million, compared with a TTM value of $85.3 million through Dec 2025, up 453.9%, and an annual FY2025 reading of -$26.7 million, down 273.38% over the prior year.
  • Change in Accured Expenses was $66.2 million for Q4 2025 at Bruker, up from -$11.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $66.2 million in Q4 2025 and bottomed at -$22.5 million in Q2 2021.
  • Average Change in Accured Expenses over 5 years is $10.5 million, with a median of $12.9 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses surged 13200.0% in 2023, then tumbled 202.78% in 2024.
  • Year by year, Change in Accured Expenses stood at $15.5 million in 2021, then decreased by 16.77% to $12.9 million in 2022, then fell by 16.28% to $10.8 million in 2023, then crashed by 202.78% to -$11.1 million in 2024, then skyrocketed by 696.4% to $66.2 million in 2025.
  • Business Quant data shows Change in Accured Expenses for BRKR at $66.2 million in Q4 2025, -$11.1 million in Q4 2024, and $20.9 million in Q3 2024.